“We are pleased with the transition from the initial launch to a phase of commercial expansion of ZUNVEYL in 2026. Our efforts in the new year focus on achieving scale of ZUNVEYL’s expansion strategy ...
Alpha Cognition, Inc. (the “Company”, “we”, “us” and “ours”) ( NASDAQ: ACOG), a commercial-stage neuroscience company focused on advancing treatments for cognitive and neuropsychiatric disorders, ...
Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali’s TransportVehicle™ (TV)-enabled investigational therapy for Hunter syndrome Expecting multiple clinical data readouts ...
The Plankton-Gratitude Yield Co. has raised $10.75 million in equity and, with leverage and tax credits, aims to buy 35 to 40 projects worth around $40 million. New York-based Plankton, a developer of ...
Alpha Funds and Alpha Aerospace Join Military and Government Leaders at 2025 MilSat Symposium MOUNTAIN VIEW, CA, UNITED STATES, November 20, 2025 /EINPresswire.com ...
Firefly Aerospace intends to make a second attempt to launch the seventh mission of its Alpha rocket by early next calendar year, after losing the original first-stage booster for the mission during ...
A long-held portfolio of 13 Brooklyn multifamily buildings, each with no more than 10 apartments, has been sold off-market by the Kupferman family to two separate buyers for $45 million, Commercial ...
- Receipt of critical license marks significant milestone for first commercial-scale manufacturing facility for Alpha DaRT ®, the innovative alpha-radiation cancer therapy designed for potent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results